| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| Ab183037-100μg | 100μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $59.90 | |
| Ab183037-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $269.90 | |
| Ab183037-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $719.90 | |
| Ab183037-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,149.90 |
| Product Name | Pritumumab (anti-Vimentin) - Primary antibody, specific to VIM, Human IgG1 |
|---|---|
| Synonyms | CTRCT30 antibodyEpididymis luminal protein 113 antibody | FLJ36605 antibody | HEL113 antibody | VIM antibody | VIME_HUMAN antibody | Vimentin antibody | epididymis secretory sperm binding protein | FLJ36605 | VIM | Vimentin |
| Specifications & Purity | RUO, ≥95%(SDS-PAGE&SEC), See COA |
| Host species | Human |
| Specificity | VIM |
| Conjugation | Unconjugated |
| Grade | RUO |
| Action Type | OTHER |
| Mechanism of action | OTHER of Vimentin other |
| Product Description |
Pritumumab (anti-Vimentin) is a natural human IgG1kappa mAb originally isolated from a regional draining lymph node of a patient with cervical carcinoma. Pritumumab (anti-Vimentin) recognizes vimentin expressing on the cell surface of the malignant tumor. Pritumumab (anti-Vimentin) can be used for glioblastoma research. |
| Isotype | Human IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 28.3 kDa (Light Chain) & 51.2 kDa (Heavy Chain), under reducing conditions; 200.5 kDa, under non-reducing conditions. |
| Purification Method | Protein A purified |
| Form | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle. |
| CAS | 499212-74-7 |
Pritumumab (anti-Vimentin) (Ab183037) - Flow Cytometry
PLVX-puro-SYMX01-P08670-HEK293 cells were stained with Pritumumab (anti-Vimentin) (Ab183037) and negative control protein respectively, washed and then followed by PE and analyzed with the FACS EC₅₀ is 81.81 nM.
Pritumumab (anti-Vimentin) (Ab183037) - SEC
The purity of Pritumumab (anti-Vimentin) (Ab183037) is more than 95% verified by HPLC.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 ZJ24F0708136 | Certificate of Analysis | Jul 11, 2024 | Ab183037 |
| ZJ24F0708135 | Certificate of Analysis | Jul 11, 2024 | Ab183037 |
| ZJ24F0708134 | Certificate of Analysis | Jul 11, 2024 | Ab183037 |
